Medical Equipment

Lipid Panel Testing Market 2026–2030: Forecast, Innovation, and Competitive Trends

February 6, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the worker heat stress monitoring wearable market from 2026–2035 with trusted insights from The Business Research Company

What market expansion outlook does the Lipid Panel Testing Market show for the 2026–2030 period?

In recent years, the lipid panel testing market has experienced substantial growth. Looking ahead, it is projected to expand from $11.61 billion in 2025 to $12.61 billion in 2026, registering a compound annual growth rate (CAGR) of 8.6%. This historical expansion can be primarily attributed to several factors, including the increasing prevalence of cardiovascular diseases, the expansion of routine health screening programs, growing awareness of cholesterol management, the adoption of automated laboratory diagnostics, and improved access to diagnostic services.

The lipid panel testing market is poised for significant expansion in the coming years. It is projected to reach $17.79 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.0%. This growth during the forecast period is driven by an increasing emphasis on preventive healthcare, a rising demand for home diagnostics, the integration of digital health platforms, the growing application of AI-assisted diagnostic interpretation, and the expansion of population health screening initiatives. Key trends expected in this period include the increasing adoption of point-of-care lipid testing, a greater use of automated lipid analyzers, a growing demand for preventive cardiovascular screening, the proliferation of home-based lipid testing kits, and an enhanced focus on early risk assessment.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10270&type=smp

What Drivers Are Shaping The Development Of The Lipid Panel Testing Market?

The increasing occurrence of cardiovascular and diabetic illnesses is anticipated to boost the expansion of the lipid panel testing market in the future. Cardiovascular diseases are defined as a category of ailments impacting the heart and its blood vessels, whereas diabetes is a persistent metabolic ailment marked by high blood glucose concentrations. These two conditions notably contribute to lipid abnormalities, rendering lipid testing crucial for prompt identification, assessing risk levels, planning treatments, and ongoing surveillance. Through lipid panel testing, medical professionals can detect dyslipidemia, inform therapeutic approaches, and mitigate the likelihood of complications like heart attack and stroke. As an illustration, in September 2025, data from the American College of Cardiology (ACC), a US-based nonprofit medical association, indicated that worldwide cardiovascular disease deaths amounted to $ 0.0192 billion (19.2 million) in 2023. Consequently, the escalating burden posed by cardiovascular and diabetic diseases is fueling the expansion of the lipid panel testing market.

Which Segments Are Contributing To The Growth Of The Lipid Panel Testing Market?

The lipid panel testing market covered in this report is segmented –

1) By Product And Services: Devices, Kits, Services

2) By Prescription Mode: Prescription-Based Testing, OTC-Based Testing

3) By Application: Hyperlipidemia, Hypertriglyceridemia, Familial Hypercholesterolemia, Hypo-Lipoproteinemia, Tangier Disease, Atherosclerosis, Other Applications

4) By End User: Hospital, Specialty Clinics And Physician Offices, Pathology Laboratories, Diagnostic Clinics, Reference Laboratories, Academic And Research Institutes, Other End-Users

Subsegments:

1) By Devices: Automated Analyzers, Point-Of-Care Testing Devices, Spectrophotometers

2) By Kits: Test Kits For Cholesterol, HDL And LDL Kits, Triglyceride Test Kits

3) By Services: Laboratory Testing Services, Diagnostic Services, Health Screening Services

What Trends Are Reshaping The Dynamics Of The Lipid Panel Testing Market?

Leading companies in the lipid panel testing market are concentrating on developing advanced solutions, such as Lp(a)-based diagnostic assays, to improve cardiovascular risk assessment. An Lp(a)-based assay is a medical test that quantifies lipoprotein(a) levels in the blood, enabling clinicians to identify individuals at heightened risk of cardiovascular diseases and provide tailored treatment recommendations. For instance, in May 2024, F. Hoffmann-La Roche AG, a Switzerland-based biotechnology and diagnostics company, launched the Tina-quant Lp(a) RxDx assay after receiving FDA Breakthrough Device Designation. This innovation measures the number of Lp(a) molecules per litre in a person’s bloodstream, providing a standardized and actionable biomarker for cardiovascular risk. Integrated into Roche’s existing serum work area (SWA) systems and cobas® platforms, it allows healthcare professionals to make informed decisions regarding Lp(a)-lowering therapies, thereby enhancing patient outcomes and supporting precision cardiovascular care. The assay simplifies Lp(a) testing, boosts diagnostic accuracy, and facilitates broader adoption of personalized lipid management strategies.

Who Are The Top-Performing Companies In The Lipid Panel Testing Market In Recent Years?

Major companies operating in the lipid panel testing market are Abbott Laboratories, Beckman Coulter Inc., F. Hoffmann-La Roche Ltd., Randox Laboratories Ltd., Thermo Fisher Scientific Inc., PTS Diagnostics, Quest Diagnostics Incorporated, Alere Inc., Boston Heart Diagnostics Corporation, Eurofins Scientific SE, Spark Diagnostics Pvt Ltd., Everlywell Inc., Horiba ABX SAS, Siemens Healthcare GmbH, Nova Biomedical Corporation, Bio-Rad Laboratories Inc., Danaher Corporation, DiaSorin S.p.A., EKF Diagnostics Holdings plc, Ortho Clinical Diagnostics LLC

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/lipid-panel-testing-global-market-report

How Does The Lipid Panel Testing Market Perform Across Major Global Regions?

North America was the largest region in the lipid panel testing market in 2025. Asia-Pacific is expected to be the fastest growing region in the global lipid panel testing market during the forecast period. The regions covered in the lipid panel testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Lipid Panel Testing Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=10270&type=smp

Browse Through More Reports Similar to the Global Lipid Panel Testing Market 2026, By The Business Research Company

Lipid Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/lipid-global-market-report

Lipid Disorder Treatment Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/lipid-disorder-treatment-global-market-report

Lipid Regulators Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/lipid-regulators-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795